Tags
- 23andMe
- 27HC
- 454 Life Sciences
- Abiraterone
- Ablynx
- academic research
- Acceleron
- acetylcholine
- addiction
- Adenovirus
- ADHD
- adult stem cells
- advanced cell technology
- aging
- Aicar
- AIDS
- AIDS research
- AIDS vaccine
- Alan Lewis
- Alan Trounson
- Albany Medical Center Prize
- alcohol
- Aled Edwards
- alemtuzumab
- Allan Jones
- alpha-7
- ALS
- Alzheimer's
- Alzheimer's test
- Ambien
- Amgen
- amyloid plaque
- amyloidosis
- anaphylactic shock
- Andreas Barner
- Animal
- Animal Rights
- Ann Arbor
- Anthony S. Fauci
- anthrax
- antibiotics
- antibodies
- Antibody
- antipsychotic
- antiviral drugs
- Anton
- Applied Biosystems
- Ardian
- artificial antibodies
- artificial artery
- artificial DNA
- artificial heart
- ASCO
- asthma
- atherosclerosis
- ATOH1
- Australia
- autism
- Avastin
- Avian flu
- Axons
- backpacks
- bacteria
- Bert Sakmann
- beta amyloid
- Bill & Melinda Gates Foundation
- biochemistry
- Biochemists
- Biocon
- biodefense
- bioengineering
- biofilms
- Biogen Idec
- Bioheart
- bioinformatics
- biologic
- biological engineering
- biomarkers
- BioPharmaIT
- Bioprospecting
- biosensors
- biosimilars
- biotech bankruptcy
- biotech investment
- biotech jobs
- bioterror
- BioTime
- birth control
- blindness
- Blood vessel
- blood vessels
- Blood-brain barrier
- Boehringer Ingelheim
- bone loss
- bone marrow
- bone repair
- brain
- brain cancer
- brain cells
- BrainCells
- breast cancer
- brevetoxin
- Bristol-Myers Squibb
- brown fat
- Bruce Ivins
- Brucella
- Buck Institute for Age Research
- Burnham Institute
- cabergoline
- calif
- California
- California Institute for Regenerative Medicine
- Cambridge
- Canada
- Cancer
- cancer cure
- Cancer Drugs
- cancer pain
- Cancer Research UK
- Cardio3 Biosciences
- Carl June
- Carmat
- Carol Zhu
- cathelicidin
- Catherine Verfaillie
- CDI
- Cell Biology
- cell division
- Cell fusion
- Center for Human Genetic Research
- Center for Stem Cell and Regenerative Medicine
- Centers for Disease Control
- central nervous system
- Centre for Medical Research and Innovation
- Charles Natanson
- chemotherapy
- Children's Hospital & Research Center Oakland
- chimera
- Chimerix
- China
- cholesterol
- Christus Stehlin Foundation
- chronic fatigue
- Chronic Pain
- Cidofovir
- Cleveland
- Clifford Reid
- clinical researchers
- Clinical Trial
- clinical trials
- cloning
- colon cancer
- compensation
- Complete Genomics
- conflict of interests
- COPD
- cord blood
- Corey Goodman
- Cougar Biotechnology
- Covance
- Craig Venter
- critics
- CRO
- CRT0066101
- CS-8958
- CVRx
- Cybrids
- cystic fibrosis
- Cytori
- Dana Farber Cancer Institute
- DARPA
- DARPP-32
- David Baker
- David E. Shaw
- David Feldheim
- David Jensen
- David Sinclair
- DaVinci Biosciences
- deals
- death
- Decode Genetics
- deltaFosB
- dementia
- Denosumab
- depression
- dermatology
- designer babies
- Diabetes
- disclosure
- DNA
- dopamine
- dosinex
- Dr. Joshua Hare
- Dr. Robert Gallo
- Dr. Zheng Cui
- Draper Laboratory
- drug abuse
- drug class
- Drug combinations
- drug combos
- drug data
- drug delivery
- drug development
- drug safety
- Drug simulation technology
- E-therapeutics
- early-stage research
- economic development
- education
- Election 2008
- Eli Lilly
- Elias Zerhouni
- Elizabeth Blackburn
- embryo
- Embryo Project
- embryos
- Emotional Disorders
- EnGeneIC
- EnGenelC Delivery Vehicle
- Enobia Pharma
- Entelos
- Entrepreneurs
- Enzymes
- Eric Lander
- Eric Topol
- Europe
- exercise
- EyeCyte
- failure
- Fanapt
- Fasudil
- fat bubbles
- Fate Therapeutics
- Fatostatin
- FDA
- FDA approval
- FDA news
- FDA regulation
- FDA update
- fertility
- Fever
- fiber optics
- Fiorenzo Omenetto
- Florida
- Fludase
- Foldit
- FoldRx
- Foot And Mouth Disease
- Fosamax
- Fragile X
- Francis Collins
- fraud
- fumagillin
- funding
- gamers
- GE Healthcare
- Genentech
- genetic engineering
- genetic sequencing
- genetic testing
- genetic variation
- genetically engineered animals
- genetics
- genome
- Genomics
- Genzyme
- George Church
- George Daly
- George Honig
- Geron
- ghrelin
- Gilead
- glaucoma
- GlaxoSmithKline
- Glycofi
- glyoxylate shunt
- GMP
- Good Cholesterol
- Graft-versus-Host Disease
- grant
- Grape Skin
- guardian
- GW1516
- H7N2
- Hani Atamna
- Hansjörg Wyss
- Haptogen
- Harold Varmus
- Harvard Medical School
- HDL-C
- HE3235
- heart
- heart attack
- heart disease
- heart muscle
- heart valves
- Helicos BioSciences
- Hendra
- Hepatitis C
- Hepregen
- High blood pressure
- HIPAA
- HIV
- Hollis-Eden
- Hongjie Dai
- Hormone Replacement Therapy
- Howard Hughes Medical Institute
- Human Embryonic Stem Cell
- Huntington's Disease
- Hwang Woo Suk
- Hybrid embryos
- Hybrids
- hypertension
- hypophosphatasia
- Ian Frazer
- Ian Mills
- IBM
- Illumina
- imaging
- immune system
- Immuneering
- immunoglobulin
- Immunology
- India
- infection
- infectious disease
- inflammation
- influenza
- Inovio Biomedical
- insulin
- International Partnership for Microbicides
- investigators
- iPill
- itching
- iZumi Bio
- James Kovach
- James Thomson
- Japan
- Jay Tenenbaum
- Joan Steitz
- John Holdren
- John Novembre
- John Quackenbush
- Johns Hopkins
- Johnson & Johnson
- Jolee Mohr
- Joseph DeSimone
- Jubilant
- Judah Folkman
- Juvenile Diabetes Research Foundation
- K-RAS gene
- Kari Stefansson
- Karl Saxe
- Kathleen Sebelius
- Kenneth Shea
- Kevin Shakesheff
- kidney cancer
- Knome
- korean researchers
- Lasker Prize
- learning disabilities
- leptin
- leukemia
- Libradyn
- lisinopril
- Liver enzymes
- Living Cell Technologies
- lodamin
- Longevity
- Lorry Lokey
- losartan
- LOXL1
- Luc Montagnier
- LucCell
- lung cancer
- M&A
- macular degeneration
- Malaria
- mannitol
- manufacturing
- Marc Cluzel
- Margaret Hamburg
- marijuana
- Marius Wernig
- market trends
- Martin Mackay
- Massachusetts
- Massachusetts Institute of Technology
- Max Planck Society
- Mayo Clinic
- Medco
- medical college of georgia
- Medivation
- melanoma
- Memories
- Merck
- Merial Animal Health
- messenger rna
- metabolic profiling
- metabolism
- metformin
- Methodist Hospital
- Michael Clarke
- Michael Krawczak
- Michael Parker
- Michigan
- microbe
- microchip
- microdosing
- Millipore
- Minnesota
- minocycline
- MIT
- molecular research
- molecules
- monoclonal antibodies
- morphine
- MRSA
- Muhammad Zaman
- multiple myeloma
- multiple sclerosis
- muscular dystrophy
- myelin
- nanobodies
- Nanoscale
- nanotechnology
- Nanotechnology regulation
- nanotechnology safety
- National Health Service
- National Institutes of Health
- National Science Foundation
- neuroblastoma
- neurons
- neurotransmitter
- neurotrophic factor
- New Jersey
- New York
- NexBio
- Nipah
- Northwestern University
- Novartis
- Novocell
- NP-C disease
- Obama Administration
- obesity
- oncology
- OncoMed
- OneWorld Health
- open-source
- Optogenetics
- Osiris
- osteoporosis
- outbreak
- outsourcing
- ovarian cancer
- Oxford Nanopore Technologies
- Oxford University
- Pacific Biosciences
- Pain therapy
- pancreas
- pancreatic cancer
- pandemic
- Parkinson Disease
- patents
- patient groups
- Paul Nurse
- Paul Stoffels
- PD173074
- peptides
- personalized medicine
- PETA
- pets
- Pfizer
- pharma gifts
- Phase I
- philanthropy
- Philips Research
- PIKAMAB
- pipeline
- PKCepsilon
- PKMzeta
- plaque
- Plauge
- Plexxikon
- PLX4032
- Post Traumatic Stress Disorder
- Post Traumatic Stress Syndrome
- postdoc
- PRDM16
- preclinical
- Preclinical Developments
- Prexige
- privacy
- PRO2000
- progenitor cells
- progeria
- prostate cancer
- protein chemistry
- protein kinase G
- proteins
- Proteostasis Therapeutics
- psychiatrists
- pulmonary fibrosis
- Punam Malik
- pyy
- Quercetin
- R&D
- R&D spending
- Ralph M. Steinman
- rare diseases
- Red Tide
- Red Wine
- regenerative medicine
- REGiMMUNE
- regulation
- Regulators
- relcovaptan
- Rene Hen
- ReNeuron
- reovirus
- reprogram
- research groups
- resistant
- restructuring
- resveratrol
- reVax
- Rheumatoid Arthritis
- Richard Pazdur
- Ritalin
- RNA
- RNAi
- Robert Epstein
- Robert Gallo
- Robert Klein
- Robert Langer
- Robert Lanza
- Roche
- Rocky Tuan
- Ronald DePinho
- Rosacea
- Rosetta@home
- Rudolf Jaenisch
- RXi Pharmaceuticals
- salary
- Salk Institute for Biological Studies
- salsalate
- Sangamo BioSciences
- Sanofi-Aventis
- Santaris Pharma
- Satori Pharmaceuticals
- schizophrenia
- Scripps Research Institute
- Seaside Therapeutics
- Serologicals
- Shinya Yamanaka
- sickle cell anemia
- side effects
- silicon
- Sinovac
- Sir Chris Evans
- Sir Leszek Borysiewicz
- Sir Martin Evans
- Sirtis Pharmaceuticals
- Sirtris
- Sirtuin
- skin cancer
- skin cells
- sleep deprivation
- Slentrol
- social networking
- sorafenib
- spin-off
- SRT501
- start-up
- Stefan Kappe
- stem cell trial
- Stem Cells
- Stemgent
- Stephen Wong
- Steven Shoelson
- STF-62247
- stomach cancer
- Stomach ulcers
- stroke
- Structural Genomics Consortium
- Substance P
- Sunburn
- supercomputer
- swine flu
- Sylvain Martel
- SynDevRx
- syntheic
- synthetic biology
- synthetic blood
- synthetic DNA
- synthetic lethality
- TAK-1 inhibitor
- TAK-491
- Takeda Pharmaceutical
- Targeted Genetics
- tasimelteon
- telomerase
- Terry McGuire
- Texas A&M
- tgAAC94
- TGF-beta
- Third Rock Ventures
- thrombosis
- tipifarnib
- tissue repair
- TNF alpha
- ToleroVax
- topiramate
- Transgenics
- Translational Genomics Research Institute
- transplants
- Treg effect
- tumors
- type I diabetes
- type II diabetes
- UC San Francisco
- United Kingdom
- universities
- University of Chicago
- University of Illinois
- University of Iowa
- university of pittsburgh
- university of texas health science center at houston
- University of Wisconsin
- vaccine
- valve
- Vanda Pharmaceuticals
- Vaptans
- vasopressin
- Venture Capital
- Vertex Pharmaceuticals
- virus
- vision loss
- Vitamin C
- vitamin D
- volunteers
- Wake Forest University
- wake forest university school of medicine
- whistleblower
- white blood cells
- William Brody
- World Stem Cell Summit
- Wyeth
- X chromosome
- X Prize
- Xceleron
- Zev Rosenwaks
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
